405 related articles for article (PubMed ID: 32324331)
21. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
Lubetzky M; Aull MJ; Craig-Schapiro R; Lee JR; Marku-Podvorica J; Salinas T; Gingras L; Lee JB; Sultan S; Kodiyanplakkal RP; Hartono C; Saal S; Muthukumar T; Kapur S; Suthanthiran M; Dadhania DM
Nephrol Dial Transplant; 2020 Jul; 35(7):1250-1261. PubMed ID: 32678882
[TBL] [Abstract][Full Text] [Related]
22. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
De Luna G; Habibi A; Deux JF; Colard M; Pham Hung d'Alexandry d'Orengiani AL; Schlemmer F; Joher N; Kassasseya C; Pawlotsky JM; Ourghanlian C; Michel M; Mekontso-Dessap A; Bartolucci P
Am J Hematol; 2020 Jul; 95(7):876-878. PubMed ID: 32282956
[No Abstract] [Full Text] [Related]
23. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options.
Holzhauser L; Lourenco L; Sarswat N; Kim G; Chung B; Nguyen AB
Am J Transplant; 2020 Oct; 20(10):2916-2922. PubMed ID: 32378314
[TBL] [Abstract][Full Text] [Related]
24. Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report.
Chen D; Yang B; Zhang Y; Chen L; Wei L; Zhang W; Wang X; Tong X; Chen Z
Medicine (Baltimore); 2020 Jun; 99(24):e20481. PubMed ID: 32541471
[TBL] [Abstract][Full Text] [Related]
25. A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
Marinaki S; Tsiakas S; Skalioti C; Lourida P; Argyraki A; Grigorakos K; Boletis I
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32708858
[TBL] [Abstract][Full Text] [Related]
26. First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Marx D; Moulin B; Fafi-Kremer S; Benotmane I; Gautier G; Perrin P; Caillard S
Am J Transplant; 2020 Jul; 20(7):1944-1946. PubMed ID: 32282977
[No Abstract] [Full Text] [Related]
27. COVID-19 in a Kidney Transplant Patient.
Wang J; Li X; Cao G; Wu X; Wang Z; Yan T
Eur Urol; 2020 Jun; 77(6):769-770. PubMed ID: 32273181
[No Abstract] [Full Text] [Related]
28. A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Chen S; Yin Q; Shi H; Du D; Chang S; Ni L; Qiu H; Chen Z; Zhang J; Zhang W
Am J Transplant; 2020 Jul; 20(7):1869-1874. PubMed ID: 32243690
[TBL] [Abstract][Full Text] [Related]
29. Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate.
Iwasaka S; Shono Y; Tokuda K; Nakashima K; Yamamoto Y; Maki J; Nagasaki Y; Shimono N; Akahoshi T; Taguchi T
J Infect Chemother; 2020 Dec; 26(12):1319-1323. PubMed ID: 32893123
[TBL] [Abstract][Full Text] [Related]
30. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
31. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 in kidney transplant recipients.
Nair V; Jandovitz N; Hirsch JS; Nair G; Abate M; Bhaskaran M; Grodstein E; Berlinrut I; Hirschwerk D; Cohen SL; Davidson KW; Dominello AJ; Osorio GA; Richardson S; Teperman LW; Molmenti EP
Am J Transplant; 2020 Jul; 20(7):1819-1825. PubMed ID: 32351040
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient.
Liu B; Wang Y; Zhao Y; Shi H; Zeng F; Chen Z
Am J Transplant; 2020 Jul; 20(7):1891-1895. PubMed ID: 32243673
[TBL] [Abstract][Full Text] [Related]
34. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
Capra R; De Rossi N; Mattioli F; Romanelli G; Scarpazza C; Sormani MP; Cossi S
Eur J Intern Med; 2020 Jun; 76():31-35. PubMed ID: 32405160
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 in posttransplant patients-report of 2 cases.
Huang J; Lin H; Wu Y; Fang Y; Kumar R; Chen G; Lin S
Am J Transplant; 2020 Jul; 20(7):1879-1881. PubMed ID: 32243697
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
Canziani LM; Trovati S; Brunetta E; Testa A; De Santis M; Bombardieri E; Guidelli G; Albano G; Folci M; Squadroni M; Beretta GD; Ciccarelli M; Castoldi M; Lleo A; Aghemo A; Vernile L; Malesci A; Omodei P; Angelini C; Badalamenti S; Cecconi M; Cremonesi A; Selmi C;
J Autoimmun; 2020 Nov; 114():102511. PubMed ID: 32713677
[TBL] [Abstract][Full Text] [Related]
37. Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report.
Hammami MB; Garibaldi B; Shah P; Liu G; Jain T; Chen PH; Kim AK; Avdic E; Petty B; Strout S; Fine DM; Niranjan-Azadi A; Garneau WM; Cameron AM; Monroy Trujillo JM; Gurakar A; Avery R
Am J Transplant; 2020 Aug; 20(8):2254-2259. PubMed ID: 32359210
[TBL] [Abstract][Full Text] [Related]
38. Early impact of COVID-19 on transplant center practices and policies in the United States.
Boyarsky BJ; Po-Yu Chiang T; Werbel WA; Durand CM; Avery RK; Getsin SN; Jackson KR; Kernodle AB; Van Pilsum Rasmussen SE; Massie AB; Segev DL; Garonzik-Wang JM
Am J Transplant; 2020 Jul; 20(7):1809-1818. PubMed ID: 32282982
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
[TBL] [Abstract][Full Text] [Related]
40. Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic.
Gleeson SE; Formica RN; Marin EP
Clin J Am Soc Nephrol; 2020 Jun; 15(6):892-895. PubMed ID: 32345749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
